JESSICA ROSENBLUM: Open Payments
NPI 1326341322 · TEMPE, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$6,977 in 85 payments from 19 companies in 2025. Trend: 2023 $3,053 · 2024 $2,417 · 2025 $6,977
Consulting: $4,260Food & beverage: $2,717
| Company | Payments | Amount |
|---|---|---|
| Botanix SB Inc | 8 | $3,683 |
| UCB, Inc. | 10 | $1,008 |
| ABBVIE INC. | 16 | $533 |
| Organon LLC | 12 | $301 |
| Regeneron Healthcare Solutions, Inc. | 8 | $282 |
| Incyte Corporation | 8 | $267 |
| Novartis Pharmaceuticals Corporation | 3 | $264 |
| Lilly USA, LLC | 3 | $173 |
| REVANCE THERAPEUTICS, INC. | 3 | $150 |
| Arcutis Biotherapeutics, Inc. | 3 | $111 |
Products named: Bimzelx, SKYRIZI, VTAMA, OPZELURA, LIBTAYO, SOFDRA, DAXXIFY, RINVOQ.
Industry payments across AZ — which companies pay providers there.
